title: Cardioversion with novel oral anticoagulants: reconfirming a 50-year-old standard.
authors.affiliation: Division of Cardiology, Lahey Hospital & Medical Center, Burlington, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts. Electronic address: matthew.r.reynolds@lahey.org.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Reynolds
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004554:Electric Countershock / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin
keywords: anticoagulation; atrial fibrillation; cardioversion; stroke